跳至主要内容
临床试验/CTRI/2022/06/043174
CTRI/2022/06/043174尚未招募未知

Studies on Prothrombin time (PT) and international normalized ratio (INR) for Anticoagulation therapy after valve Replacement.

Juno Angel J0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients of 18 years and above.
  • 2. All patients with single and double mechanical valve replacement will be enrolled.
  • 3. Patients willing to sign their informed consent form will be included in the study.

排除标准

  • 1. Any patients with severe heart failure or renal impairments
  • 2. Patients with any malignancy
  • 3. Child bearing potential population will be excluded.
  • 4. Active or latent Hepatitis B or active Hepatitis C
  • 5. Serious co morbidities such as HIV, Tuberculosis etc.
  • 6. Psychiatric illness
  • 7. Patients who deny giving informed Consent

研究者

发起方
Juno Angel J

相似试验

Studies on Anticoagulation Therapy After Valve... | 临床试验